Ascend
Rockville, MD, United States ascend-adv.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Ascend is a gene-to-GMP development partner supporting advanced therapy developers from research through commercialization. It serves customers in the US and Europe with work on gene therapies, immunotherapies, oncolytics, and vaccines from sites in Rockville, Alachua, and Munich.
Services
Chemistry, manufacturing & controls (CMC)
Provides CMC support for advanced therapy programs.
Process design
Supports process design for biomanufacturing development programs.
Process feasibility
Evaluates process feasibility for client programs.
Upstream and downstream process development
Develops upstream and downstream processes for advanced therapy products.
Assay development and qualification
Develops and qualifies assays for product and process support.
Master and working cell & virus banks
Creates master and working cell and virus banks.
Scale-up and engineering runs
Performs scale-up and engineering runs to move processes toward manufacturing.
GMP bulk drug substance
Manufactures GMP bulk drug substance.
CDMO: development & manufacturing
15 more services
- GMP aseptic fill/finish
- Analytical lot release testing
- ICH stability testing
- Regulatory guidance & filing
- Platform innovation for AAV processes
- Gene therapy formulation
- Scalable manufacturing
- Process development
- Aseptic fill-finish
- Analytics & GMP QC testing
- Viral vector long-read NGS
- Potency assay services
- EpyQ® AAV Production System
- Master and working cell and virus banks
- Scalable manufacturing process development
- Turnaround
- 2-day turnaround
- What to send
- As little as ~5E9 vg for AAV
- Minimal sample requirements
- Low volume
Capabilities
- Assays and studies
- AAV
- Fill-finish
- Process development
- NGS
- Bioreactors
- Lentivirus
22 more
- ELISA
- Cell therapy
- Stability studies
- ddPCR
- Automated immunoassay
- Dynamic light scattering
- SEC
- Full/empty methods
- Capsid concentration
- In vitro cell-based relative potency assays
- Vector genome concentration
- Infectious titre
- Residual DNA testing
- Subvisible particles
- Endotoxin
- NGS impurity characterization
- Potency assays
- VG/mL
- %full capsid
- Encapsidated genome length (NGS)
- Particle aggregation
- Visible particles
- Scale and capacity
- 2L to 500L
- 0.5L to 500L
- 10 L scale
- Up to 3000 vials per batch
- 200 to 3,000 vials per lot
- Up to 10,000 vials per lot
5 more
- 57500 sqft GMP manufacturing facility in Alachua, Florida
- 57000 sqft GMP Quality Control facility in Munich, Germany
- 72000 sqft GMP manufacturing & testing facility in Rockville, Maryland
- Three key locations
- In-house fill/finish in two of its United States locations
- Therapeutic areas
- Gene therapy
- Cell and gene therapy
- Advanced therapies
- CNS-directed gene therapies
- Immunotherapies
- Vaccines
Instruments and platforms
- Flexicon FPC50W
- Oxford Nanopore
- Stirred-tank bioreactors
- Orbital shaking bioreactors
- Rocking bioreactors
- Long-read NGS
4 more
- Droplet digital PCR (ddPCR)
- Automated immunoassay
- Dynamic light scattering
- SEC
Modalities and species
- Modalities
- Viral vector
- Cell therapy
- Vaccine
- Plasmid DNA
- Species and models
- HEK293 cell line
- Oxford Nanopore
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001Self-reported
Scope: quality management system
GMPSelf-reported
Details
- Type
- CRDMO
- Address
- 9800 Medical Center Drive • Building D Rockville, MD 20850 USA
- Sites
- Alachua, USA
- Munich, Germany
- Serves
- United States, Europe, global